Different immunophenotype and autoantibody production by peripheral blood and thyroid-derived lymphocytes in patients with Graves' disease

Experimental and Clinical Endocrinology and Diabetes

Volumn 104, Issue 1, 1996, Pages 50-58

  Aust, G ^a   Lehmann, I ^a   Heberling, H J ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b City Hospital Leipzig   (Germany)

Author keywords

Activation antigen; Antibody production; Graves' disease; Lymphocyte typing

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR; THYROID PEROXIDASE; TRANSFERRIN RECEPTOR;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPHENOTYPING; LYMPHOCYTIC INFILTRATION; MALE; MEMORY CELL; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; THYROID CELL; THYROID GLAND;

ADULT; ANTIBODY FORMATION; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, CD8; AUTOANTIBODIES; B-LYMPHOCYTES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; IODIDE PEROXIDASE; KILLER CELLS, NATURAL; MALE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; THYROID GLAND;

EID: 0030029227     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211422     Document Type: Article

References (41)

1. Afeltra A, Galeazzi M, Ferri GM, Amoroso A, De-Pita O, Porzio F, Bonomo L: Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis. Ann Rheum Dis Jun 52: 457-460, 1993a
2. + T cells in Graves' disease. Endocr Res 19: 73-85, 1993b
3. Bagnasco M, Venuti D, Prigione I, Torre GC, Ferrini S, Canonica GW: Graves' disease: Phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroid. Clin Immunol Immunopathol 47: 230-239, 1988
4. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest Suppl 97: 77-89, 1968
5. +) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis. Mol Biol Med. 3: 99-112, 1986
6. Covas MI, Esquerda A, Garcia-Rico A, Mahy N: Peripheral blood T-lymphocyte subsets in autoimmune thyroid disease. J Invest Allerg Clin Immunol 2: 131-135, 1992
7. + T cells in vitro: Characteristics and antigen-presenting cell requirements. J Exp Med 176: 1431-1437, 1992
8. Davies TF: Co-cultures of human thyroid monolayer cells and autologous T cells - impact of HLA class II antigen expression. J Clin Endocrinol Metab 61: 418-423, 1985
9. Davies TF, Concepcion ES, Ben-Nun A, Graves PN, Tarjan G: T-cell receptor V gene usage in autoimmune thyroid disease: Direct assessment in thyroid aspiration. J Clin Endocrinol Metab 76: 660-666, 1993
10. + cells in the peripheral blood and thyroid tissue of patients with Graves' disease. J Immunol 142: 4233-4240, 1988
11. Galili U, Schlesinger M: The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphhocytes or of sheep red blood cells. J Immunol 112: 1628-1632, 1974
12. + T cell clones from autoimmune thyroid tissue cannot be classified according to their lymphokine production. Scand J Immunol 32: 433-440, 1990
13. Jahn S, Kiessig ST, Lukowski A, Volk H-D, Porstmann T, Grunow R, von Baehr R: Pokeweed mitogen induced synthesis of human IgG and IgM in vitro. Technical aspects and the role of adherend cells. Biomed Biochim Acta 45: 467-476, 1986
14. Karlsson FA, Totterman TH: Immunomodulation by methimazole therapy in Graves' disease: Rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells. Clin Exp Immunol 74: 258-263, 1988
15. + cells (suppressor-inducer T cells) in thyroid tissue in patients with Graves' disease. Acta Endocrinol (Copenh) 125: 687-693, 1991
16. Londei M, Bottazzo GF, Feldmann M: Human T-cell clones from autoimmune thyroid glands: Specific recognition of autologous thyroid cells. Science. 228: 85-89, 1985
17. MacKenzie WA, Schwartz AE, Friedmann EW, Davies TF: Intrathyroidal T cell clones from patients with autoimmune thyroid disease. J Clin Endocrinol Metab 64: 818-824, 1987
18. Madec AM, Allannic H, Genetet N, Gueguen M, Genetet G, Fauchet R, Stefanutti A, Orgiazzi J: T lymphocyte subsets at various stages of hyperthyroid Graves' disease: Effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA status. J Clin Endocrinol Metab 62: 117-121, 1986
19. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med. 177: 1199-1204, 1993
20. Margolick JB, Weetman AP, Burman KD: Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: Evidence of activated T cells and production of interferon-gamma. Clin Immunol Immunopathol 47: 208-218, 1988
21. Mariotti S, del Prete GF, Mastromauro C, de Carli M, Romagnani S, Ricci M, Pinchera A: The autoimmune infiltrate of Basedow's disease: Analysis of clonal level and comparison with Hashimoto's thyroiditis. Exp Clin Endocrinol 97: 139-146, 1991
22. McIntosh RS, Watson PF, Pickerill AP, Davies R, Weetman AP: No restriction of intrathyroidal T cell receptor Vα families in the thyroid of Graves' disease. Clin Exp Immunol 91:147-152, 1993
23. Misaki T, Konishi J, Aral K, Iida Y, Kasagi K, Kuma K, Torizuka K: HLA-DR antigen expression on intrathyroidal lymphocytes and thyrocytes in Hashimoto's thyroiditis and Graves' disease: An immunohistological study. Endocrinol Jpn. 34: 257-262, 1987
24. Ohashi H, Okugawa T, Itoh M: Circulating activated T cell subsets in autoimmune thyroid diseases: Differences between untreated and treated patients. Acta Endocrinol (Copenh) 125: 502-509, 1991
25. Paolieri F, Pesce, GP, Torre GC, Canonica GW, Bagnasco M: Expression of very late activation antigen-1 on intrathyroid lymphocytes in autoimmune thyroid disease. J Endocrinol Invest 15: 63-66, 1992
26. Paschke R, Bruckner N, Schmeidl R, Pfiester P, Usadel KH: Predominant intraepithelial localization of primed T cells and immunoglobulin-producing lymphocytes in Graves' disease. Acta Endocrinol (Copenh) 124: 630-636, 1991
27. Paschke R, Vogg M, Swillens S, Usadel K H: Correlation of microsamal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease. J Clin Endocrinol Metab 77: 939-943, 1993
28. Potocnik AJ, Kinne R, Menninger H, Zacher J, Emmrich F, Kroczek RA: Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand J Immunol 31: 213-224, 1990
29. Romagnani S: Human Th1 and Th2 subsets: Regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 98: 279-282, 1992
30. Roura-Mir IC, Alcalde L, Vargas F, Tolosa E, Obiols G, Foz M, Jaraquemada D, Pujol-Borrell R: Gamma delta lymphocytes in endocrine autoimmunity: Evidence of expansion in Graves' disease but not in type 1 diabetes. Clin Exp Immunol 92: 288-295, 1993
31. + T cells. J Endocrinol Invest 16: 913-920, 1993
32. + T cells from T cell receptor transgenic mice. J Exp Med 176: 1091-1098, 1992
33. Teng WP, Cohen SB, Posnett DN, Weetman AP: T cell receptor phenotypes in autoimmune thyroid disease. J Endocrinol Invest 13: 339-342, 1990
34. Tezuka H, Eguchi K, Fukuda T, Otsubo T, Kawabe Y, Ueki Y, Matsunaga M, Shimomura C, Nakao H, Ishikawa N, et al.: Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease. J Clin Endocrinol Metab 66: 702-707, 1988
35. Ueki Y, Eguchi K, Otsubo T, Kawabe Y, Shimomura C, Matsunaga M, Tezuka H, Nakao H, Kawakami A, Izumi M, et al.: Phenotypic analyses and concanavalin-A-induced suppressor cell dysfunction of intrathyroidal lymphocytes from patients with Graves' disease. J Clin Endocrinol Metab 67: 1018-1024, 1988
36. + subsets and B cells in Graves' hyperthyroidism respond rapidly to propylthiouracil therapy: Demonstration using fine needle aspirates and two-colour laser flow cytometry. Autoimmunity 13: 35-41, 1992
37. Warford A, McLachlan SM, Malcolm AJ, Young ET, Farndon JR, Rees-Smith B: Characterization of lymphoid cells in the thyroid of patients with Graves' disease. Clin Exp Immunol 57: 626-632, 1984
38. Weetman AP, Volkman DJ, Burman KD, Margolick JB, Petrick P, Weintraub BD, Fauci AS: The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis. Clin Immunol Immunopathol 39: 139-150, 1986
39. Wilson R, McKillop JH, Pearson C, Burnett AK, Gunn I, McNicol AM, Thomson JA: Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide. Clin Exp Immunol 73: 265-268, 1988
40. Wilson R, Pearson C, McKillop JH, Burnett AK, Thomson JA: The behaviour of suppressor-inducer T cells following treatment for Graves' disease. Autoimmunity 6: 93-97, 1990
41. +T cells in autoimmune thyroid diseases. Acta Endocrinol (Copenh) 115: 282-288, 1987